187 related articles for article (PubMed ID: 23503445)
1. A pilot study investigating tumor necrosis factor-α as a potential intervening variable of atypical antipsychotic-associated metabolic syndrome in bipolar disorder.
Prossin AR; Zalcman SS; Evans SJ; McInnis MG; Ellingrod VL
Ther Drug Monit; 2013 Apr; 35(2):194-202. PubMed ID: 23503445
[TBL] [Abstract][Full Text] [Related]
2. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics related metabolic syndrome in bipolar patients.
Yumru M; Savas HA; Kurt E; Kaya MC; Selek S; Savas E; Oral ET; Atagun I
J Affect Disord; 2007 Mar; 98(3):247-52. PubMed ID: 16970993
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review and Meta-Analysis of Metabolic Syndrome Prevalence in Chinese Inpatients with Bipolar Disorder.
Tao H; Shen D; Zhou Y; Sun F; Li G; Jin W
Horm Metab Res; 2022 Sep; 54(9):587-592. PubMed ID: 35738391
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics.
Ellingrod VL; Taylor SF; Dalack G; Grove TB; Bly MJ; Brook RD; Zöllner SK; Pop-Busui R
J Clin Psychopharmacol; 2012 Apr; 32(2):261-5. PubMed ID: 22370993
[TBL] [Abstract][Full Text] [Related]
6. Association between SCAP and SREBF1 gene polymorphisms and metabolic syndrome in schizophrenia patients treated with atypical antipsychotics.
Yang L; Chen J; Li Y; Wang Y; Liang S; Shi Y; Shi S; Xu Y
World J Biol Psychiatry; 2016 Sep; 17(6):467-74. PubMed ID: 26982812
[TBL] [Abstract][Full Text] [Related]
7. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders.
Abdel Aziz K; Mohd Ahmed H; Stip E; Aly El-Gabry D
Int Clin Psychopharmacol; 2024 Jul; 39(4):257-266. PubMed ID: 38381917
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of metabolic syndrome in patients with bipolar disorder compared to a selected control group-a Northern Netherlands LifeLines population cohort study.
Schuster MP; Borkent J; Chrispijn M; Ioannou M; Doornbos B; Burger H; Haarman BCM
J Affect Disord; 2021 Dec; 295():1161-1168. PubMed ID: 34706429
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study.
Salvi V; D'Ambrosio V; Bogetto F; Maina G
J Affect Disord; 2012 Feb; 136(3):599-603. PubMed ID: 22119084
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and bipolar disorder: what should psychiatrists know?
de Almeida KM; Moreira CL; Lafer B
CNS Neurosci Ther; 2012 Feb; 18(2):160-6. PubMed ID: 22070636
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort.
Godin O; Etain B; Henry C; Bougerol T; Courtet P; Mayliss L; Passerieux C; Azorin JM; Kahn JP; Gard S; Costagliola D; Leboyer M;
J Clin Psychiatry; 2014 Oct; 75(10):1078-85; quiz 1085. PubMed ID: 25373115
[TBL] [Abstract][Full Text] [Related]
13. Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia.
Flowers SA; Baxter NT; Ward KM; Kraal AZ; McInnis MG; Schmidt TM; Ellingrod VL
Pharmacotherapy; 2019 Feb; 39(2):161-170. PubMed ID: 30620405
[TBL] [Abstract][Full Text] [Related]
14. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
Bret P; Bonnet F; Bret MC; Jaffré A
Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
[TBL] [Abstract][Full Text] [Related]
15. Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort.
Flowers SA; Evans SJ; Ward KM; McInnis MG; Ellingrod VL
Pharmacotherapy; 2017 Mar; 37(3):261-267. PubMed ID: 28035686
[TBL] [Abstract][Full Text] [Related]
16. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
[TBL] [Abstract][Full Text] [Related]
17. Total gray matter volume is reduced in individuals with bipolar disorder currently treated with atypical antipsychotics.
Birner A; Bengesser SA; Seiler S; Dalkner N; Queissner R; Platzer M; Fellendorf FT; Hamm C; Maget A; Pilz R; Lenger M; Reininghaus B; Pirpamer L; Ropele S; Hinteregger N; Magyar M; Deutschmann H; Enzinger C; Kapfhammer HP; Reininghaus EZ
J Affect Disord; 2020 Jan; 260():722-727. PubMed ID: 31563071
[TBL] [Abstract][Full Text] [Related]
18. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects.
Bengesser SA; Lackner N; Birner A; Fellendorf FT; Platzer M; Mitteregger A; Unterweger R; Reininghaus B; Mangge H; Wallner-Liebmann SJ; Zelzer S; Fuchs D; McIntyre RS; Kapfhammer HP; Reininghaus EZ
J Affect Disord; 2015 Feb; 172():367-74. PubMed ID: 25451439
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder.
Bai YM; Li CT; Tsai SJ; Tu PC; Chen MH; Su TP
BMC Psychiatry; 2016 Dec; 16(1):448. PubMed ID: 27978821
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: Population-based study: Metabolic syndrome in current depressive episode.
Moreira FP; Jansen K; Cardoso TA; Mondin TC; Magalhães PVDS; Kapczinski F; Souza LDM; da Silva RA; Oses JP; Wiener CD
J Psychiatr Res; 2017 Sep; 92():119-123. PubMed ID: 28433948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
